FDA commissioner nominee Robert Califf told Senate members the agency is open to moving quickly on sunscreen ingredient evaluations when sponsors provide the appropriate safety and efficacy evidence.
Califf addressed the issue during his Nov
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?